From July to September 2026, a commercial dairy farm trial was conducted in Boryeong, South Korea, to evaluate MATHISTIN (Rumen-protected L-histidine) from MorningBio.
Histidine is one of the key limiting amino acids in dairy cows, along with methionine and lysine, and plays an important role in milk protein synthesis.
The trial involved 58 Holstein cows and showed increased milk yield and milk fat content, while milk protein content remained stable during MATHISTIN supplementation,
despite hot and humid summer conditions.
Through continuous field trials and R&D, MorningBio remains committed to providing reliable, high-quality products to the livestock industry.
Thank you for your continued support.